|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018417,
umls-concept:C0023981,
umls-concept:C0028773,
umls-concept:C0220901,
umls-concept:C0441766,
umls-concept:C0476089,
umls-concept:C0680218,
umls-concept:C0918012,
umls-concept:C1456348,
umls-concept:C1512888,
umls-concept:C1519941
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2003-11-17
|
|
pubmed:abstractText |
To validate the prognostic value of the endometrial carcinoma prognostic index (ECPI; combined myometrium invasion, flow cytometric DNA ploidy, and morphometric mean shortest nuclear axis [MSNA]) versus classic prognosticators.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4214-21
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14615450-Adult,
pubmed-meshheading:14615450-Aged,
pubmed-meshheading:14615450-Aged, 80 and over,
pubmed-meshheading:14615450-Cell Nucleus,
pubmed-meshheading:14615450-DNA, Neoplasm,
pubmed-meshheading:14615450-Endometrial Neoplasms,
pubmed-meshheading:14615450-Female,
pubmed-meshheading:14615450-Flow Cytometry,
pubmed-meshheading:14615450-Follow-Up Studies,
pubmed-meshheading:14615450-Humans,
pubmed-meshheading:14615450-Image Processing, Computer-Assisted,
pubmed-meshheading:14615450-Incidence,
pubmed-meshheading:14615450-Middle Aged,
pubmed-meshheading:14615450-Neoplasm Invasiveness,
pubmed-meshheading:14615450-Neoplasm Staging,
pubmed-meshheading:14615450-Ploidies,
pubmed-meshheading:14615450-Prognosis,
pubmed-meshheading:14615450-Prospective Studies,
pubmed-meshheading:14615450-Receptors, Progesterone,
pubmed-meshheading:14615450-Survival Rate,
pubmed-meshheading:14615450-Tumor Markers, Biological
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
|
|
pubmed:affiliation |
Department of Pathology, Rogaland Central Hospital, Stavanger, Norway.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Validation Studies
|
